Gujarat Themis Biosyn to acquire Sanofi’s global anti-TB and anti-infective portfolio for ~€158 million in an asset acquisition, enabling immediate market access with an asset-light model.
AI Assistant
Gujarat Themis Biosyn Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.